Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after injury

Journal of Neuroscience

Volumn 18, Issue 14, 1998, Pages 5285-5293

  Mohney, Robert P ^a,b   Zigmond, Richard E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

cAMP; Isoproterenol; Secretin; Superior cervical ganglion; Sympathetic; Vasoactive intestinal peptide; VIP antagonist

Indexed keywords

CYCLIC AMP; FORSKOLIN; ISOPRENALINE; PEPTIDE HISTIDINE ISOLEUCINE; SECRETIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; FEMALE; GENE EXPRESSION; MALE; NERVE CELL CULTURE; NERVE FIBER TRANSECTION; NERVE INJURY; NONHUMAN; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; SECOND MESSENGER; SUPERIOR CERVICAL GANGLION; SYMPATHETIC NERVE CELL; SYMPATHETIC TONE;

EID: 0032527601     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-14-05285.1998     Document Type: Article

References (77)

1. Aloisi F, Rosa S, Test U, Bonsi P, Russo G, Peschle C, Levi G (1994) Regulation of leukemia inhibitory factor synthesis in cultured human astrocytes. J Immunol 152:5022-5031.
2. Ariano MA, Briggs CA, McAfee DA (1982) Cellular localization of cyclic nucleotide changes in rat superior cervical ganglion. Cell Mol Neurobiol 2:143-156.
3. Audigier S, Barberis C, Jard S (1986) Vasoactive intestinal polypeptide increases inositol phospholipid breakdown in the rat superior cervical ganglion. Brain Res 376:363-367.
4. Baldwin C, Sasek CA, Zigmond RE (1991) Evidence that some preganglionic sympathetic neurons in the rat contain vasoactive intestinal peptide- or peptide histidine isoleucine amide-like immunoreactivities. Neuroscience 40:175-184.
5. Brenneman DE, Eiden LE (1986) Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc Natl Acad Sci USA 83:1159-1162.
6. Brenneman DE, Foster GA (1987) Structural specificity of peptides influencing neuronal survival during development. Peptides 8:687-694.
7. Brenneman DE, Eiden LE, Siegel RE (1985) Neurotrophic action of VIP on spinal cord cultures. Peptides 6:35-39.
8. Colbert RA, Balbi D, Johnson A, Bailey JA, Allen JM (1994) Vasoactive intestinal peptide stimulates neuropeptide Y gene expression and causes neurite extension in PC12 cells through independent mechanisms. J Neurosci 14:7141-7147.
9. Cramer H, Johnson DG, Hanbauer I, Silberstein ND, Kopin LJ (1973) Accumulation of adenosine 3′,5′-monophosphate induced by catecholamines in the rat superior cervical ganglion in vitro. Brain Res 53:97-104.
10. Deutsch PJ, Sun Y (1992) The 38-amino acid form of pituitary adenylate cyclase activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J Biol Chem 267:5108-5113.
11. Eiden LE, Hotchkiss AJ (1983) Cyclic adenosine monophosphate regulates vasoactive intestinal polypeptide and enkephalin biosynthesis in cultured bovine chromaffin cells. Neuropeptides 4:1-9.
12. Fink JS, Verhave M, Kasper S, Tsukada T, Mandel G, Goodman RH (1988) The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer. Proc Natl Acad Sci USA 85:6662-6666.
13. Fink JS, Verhave M, Walton K, Mandel G, Goodman RH (1991) Cyclic AMP and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene. J Biol Chem 266:3882-3887.
14. Fishbein VA, Coy DH, Hocart SJ, Jiang N-Y, Mrozinski Jr JE, Mantey SA, Jensen RT (1994) A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as receptor antagonists. Peptides 15:95-100.
15. Fort P, Marty L, Piechaczyk M, el Sabrouty S, Dani C, Jeanteur P, Blanchard JM (1985) Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13:1431-1442.
16. Gilman AG, Nirenberg M (1971) Effects of catecholamines on the adenosine 3′,5′-cyclic monophosphate concentrations of clonal satellite cells of neurons. Proc Natl Acad Sci USA 68:2165-2168.
17. Gourlett P, Vandermeers A, Vandermeers-Piret M-C, De Neef P, Robberecht P (1996) Addition of the (28-38) peptide sequence of PACAP to the VIP sequence modifies peptide selectivity and efficacy. Int J Pept Protein Res 48:391-396.
18. Greenfield EM, Horowitz MC, Lavish SA (1996) Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction. J Biol Chem 271:10984-10989.
19. Hahm SH, Eiden LE (1996) Tissue-specific expression of the vasoactive intestinal peptide gene requires both an upstream tissue specific element and the 5′ proximal cyclic AMP-responsive element. J Neurochem 67:1872-1881.
20. Harden TK, McCarthy KD (1982) Identification of the beta adrenergic receptor subtype on astroglia purified from rat brain. J Pharmacol Exp Ther 222:600-605.
21. Hawrot E, Patterson PH (1979) Long-term culture of dissociated sympathetic neurons. Methods Enzymol 58:574-584.
22. Hayakawa Y, Obata K, Itoh N, Yanaihara N, Okamoto H (1984) Cyclic AMP regulation of pro-vasoactive intestinal polypeptide/PHM-27 synthesis in human neuroblastoma cells. J Biol Chem 259:9207-9211.
23. Hökfelt T, Elfvin LG, Schultzberg M, Fuxe K, Said SI, Mutt V, Goldstein M (1977) Immunohistochemical evidence of vasoactive intestinal polypeptide-containing neurons and nerve fibers in sympathetic ganglia. Neuroscience 2:885-896.
24. Hökfelt T, Fahrenkrug J, Ju G, Ceccatelli S, Tsuruo Y, Meister B, Mutt V Rundgren M, Brodin E, Terenius L, Hulting A-L, Werner S, Björklund H, Vale W (1987) Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the CNS with special 1 reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus. Neuroscience 23:827-857.
25. Houchi H, Oka M, Misbahuddin M, Morita K, Nakanishi A (1987) Stimulation by vasoactive intestinal polypeptide of catecholamine synthesis in isolate bovine adrenal chromaflin cells: possible involvement of protein kinase C. Biochem Pharmacol 36:1551-1554.
26. Hyatt-Sachs H, Schreiber RC, Bennett TA, Z igmond RE (1993) Phenotypic plasticity in adult sympathetic ganglia in vivo: effects of deafferentation and axotomy on the expression of vasoactive intestinal peptide. J Neurosci 13:1642-1653.
27. Inagaki N, Yoshida H, Mizuta M, Mizuno N, Fujii Y, Gonoi T, Miyazaki JI, Seino S (1994) Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc Natl Acad Sci USA 91:2679-2683.
28. Ip NY, Ho CK, Zigmond RE (1982) Secretin and vasoactive intestinal peptide acutely increase tyrosine 3-monooxygenase activity in the rat superior cervical ganglion. Proc Natl Acad Sci USA 79:7566-7569.
29. Ip NY, Perlman RL, Zigmond RE (1983) Acute trans-synaptic regulation of tyrosine 3-monooxygenase activity in the superior cervical ganglion: Evidence for both cholinergic and noncholinergic mechanisms. Proc Natl Acad Sci USA 80:2081-2085.
30. Ip NY, Baldwin C, Zigmond RE (1985) Regulation of the concentration of adenosine 3′,5′-cyclic monophosphate and the activity of tyrosine hydroxylase in the rat superior cervical ganglion by three neuropeptides of the secretin family. J Neurosci 5:1947-1954.
31. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S (1992) Functional expression and tissue distribution of a novel receptor for vasoactive intestinal peptide. Neuron 8:811-819.
32. Itoh N, Obata K, Yanaihara N, Okamoto H (1983) Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27. Nature 304:547-549.
33. 2+ through breakdown of phosphoinositides to induce catecholamine secretion. J Biol Chem 263:2123-2126.
34. Malhotra RK, Wakade TD, Wakade AR (1989) Cross-communication between acetylcholine and VIP in controlling catecholamine secretion by affecting cAMP, inositol triphosphate, protein kinase C, and calcium in rat adrenal medulla. J Neurosci 9:4150-4157.
35. Marshall JS, Gauldie J, Nielson L, Bienenstock J (1993) Leukemia inhibitory factor production by rat mast cells. Eur J Immunol 23:2116-2120.
36. May V, Braas KM (1995) Pituitary adenylate cyclase-activating polypeptide (PACAP) regulation of sympathetic neuron neuropeptide Y and catecholamine expression. J Neurochem 65:978-987.
37. May V, Brandenburg CA, Braas KM (1996) Axotomy and decentralization regulate pituitary adenylate cyclase activating polypeptide (PACAP) expression in rat superior cervical ganglion. Soc Neurosci Abstr 22:1998.
38. Mohney RP, Siegel RE, Zigmond RE (1994) Galanin and vasoactive intestinal peptide messenger RNAs increase following axotomy of adult sympathetic neurons. J Neurobiol 25:108-118.
39. Mulderry PK (1993) Synergistic regulation of vasoactive intestinal polypeptide expression by cyclic AMP and calcium in newborn but not adult rat sensory neurons in culture. Neuroscience 53:229-238.
40. Murphy Jr GM, Song Y, Ong E, Lee YL, Schmidt KG, Bocchini V, Eng LF (1995) Leukemia inhibitory factor mRNA is expressed in cortical astrocyte cultures but not in an immortalized microglial cell line. Neurosci Lett 184:48-51.
41. Nagamoto-Combs K, Zigmond RE (1997) Expression of leukemia inhibitory factor in a Schwann cell line is regulated with distinct time courses by different second messenger pathways. Soc Neurosci Abstr 23:884.
42. Nagata Y, Ando M, Miwa M, Kato K (1984) Effects of various forms of stimulation on the content of enolase isozymes and S-100 protein in superior cervical sympathetic ganglia excised from rats. J Neurochem 43:1205-1212.
43. Nogi H, Hashimoto H, Hagihara N, Shimada S, Yamamoto K, Matsuda T, Tohyama M, Baba A (1997) Distribution of mRNAs for pituitary adenylate cyclase-activating polypeptide (PACAP), PACAP receptor, vasoactive intestinal polypeptide (VIP), and VIP receptors in the rat superior cervical ganglion. Neurosci Lett 227:37-40.
44. O'Dorisio MS, Fleshman DJ, Qualman SJ, O'Dorisio TM (1992) Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma. Regul Pept 37:213-226.
45. Ohsawa K, Hayakawa Y, Nishiawa M, Yamagami T, Yamamoto H, Yanaihara N, Okamoto H (1985) Synergistic stimulation of VIP/ PHM-27 gene expression by cyclic AMP and phorbol esters in human neuroblastoma cells. Biochem Biophys Res Commun 132:885-891.
46. Otten U, Mueller RA, Oesch F, Thoenen H (1974) Location of an isoproterenol-responsive cyclic AMP pool in adrenergic nerve cell bodies and its relationship to tyrosine 3-monooxygenase induction. Proc Natl Acad Sci USA 71:2217-2221.
47. Pincus DW, DiCicco-Bloom EM, Black IB (1990) Vasoactive intestinal peptide regulates mitosis, differentiation, and survival of cultured sympathetic neuroblasts. Nature 343:564-567.
48. Pollock JH, Blaha MJ, Lavish SA, Steveson S, Greenfield EM (1996) In vivo demonstration that parathyroid hormone and parathyroid hormone-related protein stimulate expression by osteoblasts of interleukin-6 and leukemia inhibitory factor. J Bone Miner Res 11:754-759.
49. Rao MS, Escary J, Sun Y, Perreau J, Patterson PH, Zigmond RE, Brulet P, Landis SC (1993a) Leukemia inhibitory factor mediates an injury response but not a target-mediated developmental transmitter switch in sympathetic neurons. Neuron 11:1175-1185.
50. Rao MS, Sun Y, Vaidyanathan U, Landis SC, Zigmond RE (1993b) Regulation of substance P is similar to that of vasoactive intestinal peptide after axotomy or explantation of the rat superior cervical ganglion. J Neurobiol 24:571-580.
51. Roskoski Jr R, White L, Knowlton R, Roskoski LM (1989) Regulation of tyrosine hydroxylase activity in rat PC12 cells by neuropeptides of the secretin family. Mol Pharmacol 36:925-931.
52. Rougon G, Noble M, Mudge AW (1983) Neuropeptides modulate the β-adrenergic response of purified astrocytes in vitro. Nature 305:715-717.
53. Sakimura K, Kushiya E, Ogura A, Kudo Y, Katagiri T, Takahashi Y (1995) Upstream and intron regulatory regions for expression of the rat neuron-specific enolase gene. Mol Brain Res 28:19-28.
54. Sasek CA, Zigmond RE (1989) Localization of vasoactive intestinal peptide-and peptide histidine isoleucine amide-like immunoreactivities in the rat superior cervical ganglion and its nerve trunks. J Comp Neurol 280:522-532.
55. Schwarzschild MA, Vale W, Corigliano-Murphy AC, Pisano JJ, Ip NY, Zigmond RE (1989) Activation on tyrosine hydroxylase by peptides of the secretin-glucagon family: structure-function studies. Neuroscience 13:159-167.
56. Segerson TP, Lam KS, Cacicedo L, Minamitani N, Fink JS, Lechan RM, Reichlin S (1989) Thyroid hormone regulates vasoactive intestinal peptide (VIP) mRNA levels in the rat anterior pituitary gland. Endocrinology 125:2221-2223.
57. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170-175.
58. Sun Y, Zigmond RE (1996) Involvement of leukemia inhibitory factor in the increases in galanin and vasoactive intestinal peptide mRNA and the decreases in neuropeptide Y and tyrosine hydroxylase mRNA in sympathetic neurons after axotomy. J Neurochem 67:1751-1760.
59. Sun Y, Rao MS, Landis SC, Zigmond RE (1992) Depolarization increases vasoactive intestinal peptide- and substance P-like immunoreactivities in cultured neonatal and adult sympathetic neurons. J Neurosci 12:3717-3728.
60. Sun Y, Rao MS, Zigmond RE, Landis SC (1994) Regulation of vasoactive intestinal peptide expression in sympathetic neurons in culture and after axotomy: The role of cholinergic differentiation factor/leukemia inhibitory factor. J Neurobiol 25:415-430.
61. Sun Y, Landis SC, Zigmond RE (1996) Signals triggering the induction of leukemia inhibitory factor in sympathetic superior cervical ganglia and their nerve trunks after axonal injury. Mol Cell Neurosci 7:152-163.
62. Symes A, Lewis S, Corpus L, Rajan P, Hyman SE, Fink JS (1994) STAT proteins participate in the regulation of the vasoactive intestinal peptide gene by the ciliary neurotrophic factor family of cytokines. Mol Endocrinol 8:1750-1763.
63. Symes AJ, Rajan P, Corpus L, Fink JS (1995) C/EBP-related sites in addition to a Stat site are necessary for ciliary neurotrophic factor-leukemia inhibitory factor-dependent transcriptional activation by the vasoactive intestinal peptide cytokine response element. J Biol Chem 270:8068-8075.
64. Tanaka S, Koike T (1994) Vasoactive intestinal peptide suppresses neuronal cell death induced by nerve growth factor deprivation in rat sympathetic ganglion cells in vitro. Neuropeptides 26:103-111.
65. Tatemoto K, Mutt V (1981) Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagonsecretin family. Proc Natl Acad Sc USA 78:6603-6607.
66. Tsukada T, Fink JS, Mandel G, Goodman RH (1987) Identification of a region in the human vasoactive intestinal polypetide gene responsible for regulation by cyclic AMP. J Biol Chem 262:8743-8747.
67. Tsukada T, Fukushima M, Takebe H, Nakai Y (1995) Vasoactive intestinal peptide gene expression in the rat pheochromocytoma cell line PC12. Mol Cell Endocrinol 107:231-239.
68. Volle RL, Patterson BA (1982) Regulation of cyclic AMP accumulation in a rat sympathetic ganglion: effects of vasoactive intestinal polypeptide. J Neurochem 39:1195-1197.
69. Waymire JC, Craviso GL, Lichteig K, Johnston JP, Baldwin C, Zigmond RE (1991) Vasoactive intestinal peptide stimulates catecholamine biosynthesis in isolated adrenal chromaffin cells: evidence for a cyclic AMP-dependent phosphorylation and activation of tyrosine hydroxylase. J Neurochem 57:1313-1324.
70. Wessels-Reiker M, Basiboina R, Howlett AC, Strong R (1993) Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors. J Neurochem 60:1018-1029.
71. Wollman Y, Lilling G, Goldstein MN, Fridkin M, Gozes I (1993) Vasoactive intestinal peptide: a growth promoter in neuroblastoma cells. Brain Res 624:339-341.
72. Yasuda T, Sobue G, Mitsuma T, Takahashi A (1988) Peptidergic and adrenergic regulation of the intracellular 3′,5′-cyclic adenosine monophosphate content in cultured rat Schwann cells. J Neurol Sci 88:315-325.
73. Zigmond RE (1997) LIF, NGF, and the cell body response to axotomy. The Neuroscientist 3:176-185.
74. Zigmond RE, Mackay AVP (1974) Dissociation of stimulatory and synthetic phases in the induction of tyrosine hydroxylase. Nature 247:112-113.
75. Zigmond RE, Schwarzschild MA, Rittenhouse AR (1989) Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu Rev Neurosci 12:415-416.
76. Zigmond RE, Hyatt-Sachs H, Baldwin C, Qu XM, Sun Y, McKeon TW, Schreiber RC, Vaidyanathan U (1992) Phenotypic plasticity in adult sympathetic neurons: Changes in neuropeptide expression in organ culture. Proc Natl Acad Sci USA 89:1507-1511.
77. Zigmond RE, Hyatt-Sachs H, Mohney RP, Schreiber RC, Shadiack AM, Sun Y, Vaccariello SA (1996) Changes in neuropeptide phenotype after axotomy of adult peripheral neurons and the role of leukemia inhibitory factor. Perspect Dev Neurobiol 4:75-90.